APA (7th ed.) Citation

A, B., M, E., JP, D., U, B., & JA, S. (2026). Appendicitis and multiple sclerosis disease-modifying therapies: A disproportionality analysis of the FDA adverse event reporting system. Multiple sclerosis and related disorders, 109, 107106. https://doi.org/10.1016/j.msard.2026.107106

Chicago Style (17th ed.) Citation

A, Balshi, Esser M, Dempsey JP, Baber U, and Sloane JA. "Appendicitis and Multiple Sclerosis Disease-modifying Therapies: A Disproportionality Analysis of the FDA Adverse Event Reporting System." Multiple Sclerosis and Related Disorders 109 (2026): 107106. https://doi.org/10.1016/j.msard.2026.107106.

MLA (9th ed.) Citation

A, Balshi, et al. "Appendicitis and Multiple Sclerosis Disease-modifying Therapies: A Disproportionality Analysis of the FDA Adverse Event Reporting System." Multiple Sclerosis and Related Disorders, vol. 109, 2026, p. 107106, https://doi.org/10.1016/j.msard.2026.107106.